Toronto's Genesys Capital, successful biotech and health care investors, raise a new fund
Genesys III raises most of $125 mln target from HarbourVest, other LPs - PE HUB
Genesys Capital has collected most of the $125 million target set for its third venture fund, adding to the momentum felt of late in Canada’s life-sciences sector. Genesys Ventures III initially closed at $90 million in committed capital, the Toronto-based firm announced this week. That puts the fund more than 70 percent of the way to reaching its final goal, expected early next year, Managing Director Damian Lamb told PE Hub Canada.
Join in on the conversation with Ella Korets-Smith when you subscribe to Toronto Health.